한국어
English
日本語
中文(简体)COVAXFLU (Influenza Split Vaccine)
15μg
Prescription medication · Combination
Korea Vaccine Co., Ltd.
It stimulates the immune system with influenza B virus antigens to produce a preventive effect.
MFDS ingredient code M267776
This ingredient is an inactivated antigen of the influenza B virus, included in the vaccine to help the immune system recognize and respond to the virus. It is primarily used for the prevention of influenza infection.
Once injected into the body, this antigen is recognized by immune cells, promoting the production of antibodies. The antibodies formed in this way respond quickly to block infection when the actual influenza virus invades.
Approved uses differ by product. Check each product's information for its actual use.
This antigen is derived from a specific strain of the influenza B virus and is specialized for the B type virus, unlike other influenza virus antigens. It is inactivated in the form of a split vaccine, ensuring high safety.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.